Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,211,673
-
Share change
-
+4,210,673
-
Total reported value
-
$69,362,000
-
Put/Call ratio
-
140%
-
Price per share
-
$3.62
-
Number of holders
-
26
-
Value change
-
+$15,242,000
-
Number of buys
-
25
Institutional Holders of AVEO PHARMACEUTICALS INC - COM NEW (AVEO) as of Q1 2020
As of 31 Mar 2020,
AVEO PHARMACEUTICALS INC - COM NEW (AVEO) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,211,673 shares.
The largest 10 holders included
NEA Management Company, LLC, VANGUARD GROUP INC, BlackRock Inc., JACOBS LEVY EQUITY MANAGEMENT, INC, SABBY MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, WINTON GROUP Ltd, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Evercore Wealth Management, LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.